CPIX
Price
$5.64
Change
-$0.13 (-2.25%)
Updated
Jun 3, 04:52 PM (EDT)
Capitalization
86.45M
69 days until earnings call
Intraday BUY SELL Signals
LFCR
Price
$5.67
Change
+$0.22 (+4.04%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
212.68M
58 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CPIX vs LFCR

Header iconCPIX vs LFCR Comparison
Open Charts CPIX vs LFCRBanner chart's image
CPIX vs LFCR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CPIX vs. LFCR commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPIX is a Hold and LFCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (CPIX: $5.77 vs. LFCR: $5.67)
Brand notoriety: CPIX and LFCR are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CPIX: 8% vs. LFCR: 147%
Market capitalization -- CPIX: $86.45M vs. LFCR: $212.68M
CPIX [@Pharmaceuticals: Generic] is valued at $86.45M. LFCR’s [@Pharmaceuticals: Generic] market capitalization is $212.68M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPIX’s FA Score shows that 0 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • CPIX’s FA Score: 0 green, 5 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both CPIX and LFCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPIX’s TA Score shows that 3 TA indicator(s) are bullish while LFCR’s TA Score has 5 bullish TA indicator(s).

  • CPIX’s TA Score: 3 bullish, 4 bearish.
  • LFCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than CPIX.

Price Growth

CPIX (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LFCR (@Pharmaceuticals: Generic) price change was +17.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.16%. For the same industry, the average monthly price growth was +24.29%, and the average quarterly price growth was +16.47%.

Reported Earning Dates

CPIX is expected to report earnings on Aug 11, 2026.

LFCR is expected to report earnings on Jul 31, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-2.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LFCR($213M) has a higher market cap than CPIX($86.5M). CPIX YTD gains are higher at: 44.975 vs. LFCR (-30.685). CPIX has higher annual earnings (EBITDA): -1.25M vs. LFCR (-8.81M). LFCR has more cash in the bank: 20.8M vs. CPIX (11M). CPIX has less debt than LFCR: CPIX (10.1M) vs LFCR (149M). LFCR has higher revenues than CPIX: LFCR (129M) vs CPIX (41.9M).
CPIXLFCRCPIX / LFCR
Capitalization86.5M213M41%
EBITDA-1.25M-8.81M14%
Gain YTD44.975-30.685-147%
P/E RatioN/A51.23-
Revenue41.9M129M32%
Total Cash11M20.8M53%
Total Debt10.1M149M7%
FUNDAMENTALS RATINGS
CPIX vs LFCR: Fundamental Ratings
CPIX
LFCR
OUTLOOK RATING
1..100
3626
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3783
P/E GROWTH RATING
1..100
996
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LFCR's Valuation (88) in the Industrial Specialties industry is in the same range as CPIX (100) in the Pharmaceuticals Other industry. This means that LFCR’s stock grew similarly to CPIX’s over the last 12 months.

CPIX's Profit vs Risk Rating (69) in the Pharmaceuticals Other industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that CPIX’s stock grew similarly to LFCR’s over the last 12 months.

CPIX's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that CPIX’s stock grew similarly to LFCR’s over the last 12 months.

CPIX's Price Growth Rating (37) in the Pharmaceuticals Other industry is somewhat better than the same rating for LFCR (83) in the Industrial Specialties industry. This means that CPIX’s stock grew somewhat faster than LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (6) in the Industrial Specialties industry is significantly better than the same rating for CPIX (99) in the Pharmaceuticals Other industry. This means that LFCR’s stock grew significantly faster than CPIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPIXLFCR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 23 days ago
83%
Bearish Trend 9 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CPIX
Daily Signal:
Gain/Loss:
LFCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBBYX7.20N/A
N/A
AB Relative Value Advisor
HSCSX25.55N/A
N/A
Homestead Small Company Stock
BRWAX30.10N/A
N/A
MFS Blended Research Growth Eq A
JDIVX18.67N/A
N/A
JHancock Disciplined Value Intl NAV
EEIFX10.67N/A
N/A
Monteagle Enhanced Equity Income Instl

CPIX and

Correlation & Price change

A.I.dvisor tells us that CPIX and ACB have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPIX and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPIX
1D Price
Change %
CPIX100%
+1.23%
ACB - CPIX
27%
Poorly correlated
-3.16%
QNTM - CPIX
26%
Poorly correlated
-2.67%
LFCR - CPIX
22%
Poorly correlated
+12.37%
SUPN - CPIX
22%
Poorly correlated
-1.54%
BNKK - CPIX
22%
Poorly correlated
+2.41%
More